New Canadian patent approval for Episurf Medical
Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the Canadian Intellectual Property Office (CIPO). The patent, entitled “System and method for creating a decision support material indicating damage to an anatomical joint”, relates to 3D-based assessment of joint lesions. “This is an important patent for Episurf in the field of medical imaging and surgical pre-planning, and we are happy to get it approved in strategically selected countries”, says Katarina Flodström, COO, Episurf Medical.